Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
The Oncologist|March 25, 2010
FDA approval summary: temsirolimus as treatment for advanced renal cell carcinomaVirginia E Kwitkowski, Tatiana M Prowell, Amna Ibrahim, et al.
The Oncologist|July 19, 2018
FDA Supplemental Approval: Blinatumomab for Treatment of Relapsed and Refractory Precursor B-Cell Acute Lymphoblastic LeukemiaE Dianne Pulte, Jonathon Vallejo, Donna Przepiorka, et al.
AJR. American Journal of Roentgenology|June 1, 1999
Treatment of venous outflow stenoses in thigh grafts with WallstentsB Funaki, G X Szymski, J A Leef, et al.
Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics|September 26, 2012
Controlling the formation of a monolayer of cytochrome P450 reductase onto Au surfacesJ H Convery, C I Smith, B Khara, et al.
American Journal of Physiology. Heart and Circulatory Physiology|February 19, 2021
Human iPSC-engineered cardiac tissue platform faithfully models important cardiac physiologyWillem J de Lange, Emily T Farrell, Caroline R Kreitzer, et al.
Osteoarthritis and Cartilage|December 14, 2011
Osteoarthritis-like changes in the heterozygous sedc mouse associated with the HtrA1-Ddr2-Mmp-13 degradative pathway: a new model of osteoarthritisD W Holt, M L Henderson, C E Stockdale, et al.
Clinical Pharmacology and Therapeutics|February 3, 2018
Quantitative Relationship Between AUEC of Absolute Neutrophil Count and Duration of Severe Neutropenia for G-CSF in Breast Cancer PatientsLiang Li, Lian Ma, Sarah J Schrieber, et al.
The Oncologist|April 14, 2018
FDA Approval Summary: Mylotarg for Treatment of Patients with Relapsed or Refractory CD33-Positive Acute Myeloid LeukemiaKelly J Norsworthy, Chia-Wen Ko, Jee Eun Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 2, 2019
FDA Approval Summary: Mogamulizumab-kpkc for Mycosis Fungoides and Sézary SyndromeYvette L Kasamon, Haiyan Chen, R Angelo de Claro, et al.
The Oncologist|March 28, 2019
FDA Approval Summary: Brentuximab Vedotin in First-Line Treatment of Peripheral T-Cell LymphomaNicholas C Richardson, Yvette L Kasamon, Haiyan Chen, et al.
Pageof 26